BC
Boxer Capital Portfolio holdings
AUM
$2.04B
This Quarter Return
-0.47%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$2.51B
AUM Growth
+$2.51B
(-12%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-5.83%
Top 10 Holdings %
Top 10 Hldgs %
57.19%
Holding
95
New
6
Increased
6
Reduced
12
Closed
23
Top Buys
| 1 |
SPDR S&P Biotech ETF
XBI
|
$246M |
| 2 |
Relay Therapeutics
RLAY
|
$42.2M |
| 3 |
Fate Therapeutics
FATE
|
$29.3M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$16.8M |
| 5 |
PMV Pharmaceuticals
PMVP
|
$13.2M |
Top Sells
| 1 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$71.6M |
| 2 |
argenx
ARGX
|
$51.6M |
| 3 |
CNTB
Connect Biopharma
CNTB
|
$50.4M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
$43.7M |
| 5 |
Fulcrum Therapeutics
FULC
|
$35.3M |
Sector Composition
| 1 | Healthcare | 89.32% |
| 2 | Financials | 0.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $293M | 11.39% | 2,000,000 | – | – |
|
|
2
SPDR S&P Biotech ETF
XBI
$5.07B
| $246M | 9.57% | +2,200,000 | New | +$246M |
|
3
iTeos Therapeutics
ITOS
| $202M | 7.86% | 4,345,016 | – | – |
|
|
ONC
4
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $135M | 5.26% | 500,000 -264,188 | -35% | -$71.6M |
|
|
SWTX
5
DELISTED
SpringWorks Therapeutics
SWTX
| $129M | 5% | 2,075,905 | – | – |
|
6
Cytokinetics
CYTK
$4.23B
| $95.7M | 3.72% | 2,100,000 | – | – |
|
7
Tyra Biosciences
TYRA
$675M
| $90.7M | 3.52% | 6,448,359 +125,000 | +2% | +$1.76M |
|
8
Revolution Medicines
RVMD
$7.1B
| $87.7M | 3.41% | 3,484,264 | – | – |
|
|
9
Relay Therapeutics
RLAY
$619M
| $82M | 3.18% | 2,669,132 +1,375,000 | +106% | +$42.2M |
|
10
Tango Therapeutics
TNGX
$747M
| $75.2M | 2.92% | 6,871,642 | – | – |
|
|
11
PMV Pharmaceuticals
PMVP
$74.2M
| $65.6M | 2.55% | 2,838,236 +570,000 | +25% | +$13.2M |
|
12
Merus
MRUS
$4.98B
| $60.4M | 2.35% | 1,900,000 | – | – |
|
13
Arcus Biosciences
RCUS
$1.13B
| $58M | 2.25% | 1,432,200 -652,683 | -31% | -$26.4M |
|
|
BPMC
14
DELISTED
Blueprint Medicines
BPMC
| $54.3M | 2.11% | 507,374 +82,374 | +19% | +$8.82M |
|
15
IDEAYA Biosciences
IDYA
$2.15B
| $52.1M | 2.02% | 2,202,812 | – | – |
|
|
SAGE
16
DELISTED
Sage Therapeutics
SAGE
| $46.5M | 1.81% | 1,094,000 | – | – |
|
17
AnaptysBio
ANAB
$569M
| $45.2M | 1.75% | 1,300,000 | – | – |
|
18
Nuvation Bio
NUVB
$1.02B
| $36.9M | 1.43% | 4,341,009 | – | – |
|
19
Nurix Therapeutics
NRIX
$714M
| $35.5M | 1.38% | 1,224,892 | – | – |
|
|
KNTE
20
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $32.7M | 1.27% | 1,847,559 | – | – |
|
21
Rocket Pharmaceuticals
RCKT
$354M
| $32M | 1.24% | 1,466,051 | – | – |
|
|
22
Fate Therapeutics
FATE
$120M
| $29.3M | 1.14% | +500,000 | New | +$29.3M |
|
23
Gossamer Bio
GOSS
$562M
| $27.8M | 1.08% | 2,462,358 | – | – |
|
24
Amicus Therapeutics
FOLD
$2.34B
| $26.9M | 1.04% | 2,325,000 | – | – |
|
25
Avidity Biosciences
RNA
$5.99B
| $26.7M | 1.04% | 1,121,327 | – | – |
|